Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05267327
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-03-04
First Post:
2022-02-28
Brief Title:
A Prospective Post-Marketing Observational Safety Study of Verzenios Abemaciclib Among Breast Cancer Patients in China Verzenios Abemaciclib Among Breast
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-28
First Submit QC Date:
March 3 2022
Study First Post Date:
2022-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-03
Last Update Post Date:
2022-03-04
Last Update Post Date Type:
ACTUAL